¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÀåÇÐȸ ¿µÈ£³².ÁߺΠ¼øȯ±âÇÐȸ ¿¬¼ö°­Á : 2019-06-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÀåÇÐȸ ¿µÈ£³².ÁߺΠ¼øȯ±âÇÐȸ ¿¬¼ö°­Á : 2019-06-29
±³À°ÀÏÀÚ : 2019-06-29
±³À°Àå¼Ò : ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ  
±³À°ÁÖÁ¦ : ¿µÈ£³².ÁߺΠ¼øȯ±âÇÐȸ ¿¬¼ö°­ÁÂ
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ¿ï°æÁöȸ  
´ã´çÀÚ : Á¶º°
¿¬¶ôó : 051-890-8676  
À̸ÞÀÏ : cvcenter@hanmail.net      
±³À°Á¾·ù : ³»°úÀÇ»çÇÐ, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 10:10~10:30 The Updated Role of Aspirin for Primary Prevention of ASCVD  ¹Ú¿ëÈÖ(°æ»óÀÇ´ë) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 10:30~10:50 New Lipid-Lowering Guidelines: Goals and Strategies to Improve Outcomes  °­»ó¿í(´ë±¸º¸Èƺ´¿ø) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 10:50~11:10 How to Approach to and Manage Resistant Hypertension  ±è¼ÛÀÌ(Á¦ÁÖÀÇ´ë) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 11:10~11:30 Review of Fourth universal definition of myocardial infarction  ÃÖ¿õ±æ(°Ç±¹ÀÇ´ë) 
Åä·Ð 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 11:30~11:50 discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 11:50~12:10 Æ¯°­ 1. The effect of evolocumab and its practical use  Á¶¿ë¶ô(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 12:10~12:30 Æ¯°­ 2. Translate Ticagrelor scientific evidence into clinical practice  ÀåÀç½Ä(ÀÎÁ¦ÀÇ´ë) 
½Ä»ç 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 12:30~13:00 Lunch  () 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 13:00~13:15 Timing and method of sinus conversion in Patients with AF and Heart Failure  Á¤·¡¿µ(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 13:15~13:30 How to treat Wolff-Parkinson-White syndrome?   ¹ÚÁ¾¼º(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 13:30~13:45 What Should We Know for ICD Therapy?  ±èż®(Ä«Å縯ÀÇ´ë) 
Åä·Ð 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 13:45~14:00 discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 14:00~14:15 Echocardiographic evaluation and management of Ascending Aortic Aneurysm  ±èÀÎö(°è¸íÀÇ´ë) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 14:15~14:30 How to manage severe secondary Tricuspid Regurgitation?  ÀåÁ¤À±(°æ»óÀÇ´ë) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 14:30~14:45 How to Use Cardiac Imaging for Therapeutic Approach in HF  À±ÇöÁÖ(Àü³²ÀÇ´ë) 
Åä·Ð 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 14:45~15:00 discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 15:00~15:15 Coffee break and Exhibition Tour  () 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 15:15~15:30 Vasopressors versus Inotropes: How to choose in Various Situations of HF?  ÀÌÁÖÈñ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 15:30~15:45 Cardiorenal syndrome: A Review  À̼ö¿ë(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 15:45~16:00 What Should We Know for CRT Therapy?  À±³²½Ä(Àü³²ÀÇ´ë) 
Åä·Ð 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 16:00~16:15 discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 16:15~16:30 Management of stable angina : An update  ¹Ú±ÙÈ£(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 16:30~16:45 Femoro-popliteal intervention  ¹Ú»óÈ£(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 16:45~17:00 Interventional therapy for valvular heart disease  ÀÌöÇö(°è¸íÀÇ´ë) 
Åä·Ð 06-29 ºÎ»ê º¤½ºÄÚ 2Àü½Ã°ü 3Ãþ 17:00~17:15 discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÀåÇÐȸ ¿µÈ£³².ÁߺΠ¼øȯ±âÇÐȸ ¿¬¼ö°­Á : 2019-06-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °æÈñ´ëÇб³º´¿ø 2019³â ´ëÇÑ°í°üÀýÇÐȸ Áø·áÁöħ ½ÉÆ÷Áö¿ò : 2019-06-29
´ÙÀ½±Û ÀÎÁ¦´ëÇб³ ÇØ¿î´ë¹éº´¿ø ´ëÇѳúÁ¹ÁßÇÐȸ 2019³â 6¿ù ¿µÈ£³² ³úÁ¹Áß º¸¼ö±³À° : 2019-06-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21152 ºÎ»ê ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ¿µ³²Áöȸ ÇÏ°èÁý´ãȸ : 2024-07-11 0 32 2024-07-01
21151 ºÎ»ê ´ëÇѺñ´¢ÀÇÇÐȸ 311ȸ Çмú´ëȸ(Àü¸³¼± ¾Ï) : 2024-07-11 0 31 2024-07-01
21150 ºÎ»ê ´ëÇÑ°£ÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ : 2024-07-11 0 35 2024-07-01
21149 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ (¿Â¶óÀÎ) KSMO 7¿ù ºÐ±âÁý´ãȸ : 2024-07-11 0 25 2024-07-01
21148 ÀÎõ Çѱ¹¿©ÀÚÀÇ»çȸ ÀÎõÁöȸ 7¿ù Çмú½ÉÆ÷Áö¾ö(Ä¡¸Å) : 2024-07-10 0 25 2024-07-01
21147 ¼­¿ï Á¦137ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ Áý´ãȸ : 2024-07-10 0 25 2024-07-01
21146 ¿ï»ê ¿ï»ê À̺ñÀÎÈÄ°ú Çмú ¼¼¹Ì³ª : 2024-07-09 0 31 2024-07-01
21145 ´ëÀü ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ´ëÀüÃæûÁöȸ 7¿ù ¿¬¼ö°­Á : 2024-07-09 0 29 2024-07-01
21144 ¼­¿ï 2024 ´ëÇÑ»êºÎÀΰú³»ºÐºñÇÐȸ Á¦33Â÷ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-07-07 0 28 2024-07-01
21143 ´ëÀü 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ´ëÀüÃæûÁöȸ ¿¬¼ö°­Á : 2024-07-07 0 28 2024-07-01
21142 ¼­¿ï 2024³â Á¦11ȸ ´ëÇѳ²¼º°úÇÐȸ-´ëÇѺñ´¢ÀÇÇаúÀÇ»çȸ °øµ¿½ÉÆ÷Áö¾ö : 2024-07-07 0 25 2024-07-01
21141 ¿ï»ê ¿ï»ê´ëÇб³º´¿ø ½Å°æ¿Ü°ú ½ÉÆ÷Áö¿ò : 2024-07-06 0 26 2024-07-01
21140 ´ë±¸ Á¦7ȸ °æºÏ´ëÇб³ ¾È°úÇб³½Ç ½ÉÆ÷Áö¾ö : 2024-07-06 0 26 2024-07-01
21139 ¼­¿ï 2024 ´ëÇѵΰæºÎ¿Ü°úÇÐȸ ÃÊÀ½ÆÄ ¿öÅ©¼ó : 2024-07-06 0 25 2024-07-01
21138 ±¤ÁÖ 2024 Àü³²´ëÇб³º´¿ø Á¤½Å°Ç°­ÀÇÇаú ±¹Á¦½ÉÆ÷Áö¾ö : 2024-07-05 0 26 2024-07-01
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷